All posts by Jason White

MedGenome partners with ZellNet Consulting to offer powerful genomics solutions in immune-oncology research

ZellNet will be a distributor for MedGenome’s OncoPept™ – a powerful end to end genomics platform to accelerate immune-oncology research.

FOSTER CITY, CA, UNITED STATES, June 4, 2016 /EINPresswire.com/ — MedGenome announced a strategic partnership with ZellNet Consulting – a trusted provider of immune monitoring services for over 18 years.

This arrangement seamlessly integrates MedGenome’s cancer immunotherapy genomics platform with ZellNet’s immune monitoring services. This partnership will facilitate present customers of ZellNet’s immune monitoring services to quickly expand their cancer immunotherapy research into the genomics space by leveraging the power of next-generation sequencing-based approaches of neo-antigen and neo-epitope prediction. Additionally, they will have the option to interrogate the tumor microenvironment to understand the immune cell content, cytokine network and pro-inflammatory or immune-suppressive pathways in the tumor. The OncoPept platform offered through ZellNet will enhance their current service offerings with upstream genomics to serve the customer base of both MedGenome and ZellNet.

“ZellNet is excited about the opportunity to expand its offered services with MedGenome’s cutting-edge OncoPept™ platform, a logical and timely extension” says Sylvia Janetzki, President, Zellnet Consulting “The partnership allows us to integrate important steps within the translational research and vaccine development pipeline: from what to monitor to how to monitor. Customers can continue relying on ZellNet’s superior service standards. We are proud to partner with such an exceptional company as MedGenome, and look forward to passing the advantages of this high value addition to our customers”

MedGenome is the only Next Generation Sequencing (NGS) service provider offering immune oncology researchers an enduring science-driven partnership to deliver quicker, more affordable, customized solutions to achieve superior therapeutic impact of checkpoint control inhibitors and cancer vaccines through its cancer immunotherapy genomics platform, OncoPept™.

About MedGenome

MedGenome (http://www.medgenome.com) is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Its unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized health care. MedGenome is a market leader for genomic diagnostics in South Asia and a leading provider of genomics research services globally. It is also a founding member of GenomeAsia 100K initiative to sequence 100,000 genomes in South, North and East Asia.

Our NGS lab in Foster City, California is ISO 15189 compliant, CLIA certified and CAP accredited.

About ZellNet

ZellNet Consulting (http://www.zellnet.com) is a service and consulting company specialized in functional immune monitoring techniques and their advancement. ZellNet offers a wide variety of consulting, statistical and assay evaluation services as well as seminars and workshops for Elispot and flow cytometry and their setup for immune monitoring purposes, and conducts business world-wide. ZellNet cooperates with many organizations and institutions including the CIC, C-IMT, and Elispot Resource Group to enhance the knowledge about and to improve and harmonize the performance of functional immune monitoring assay including sample handling. It is also a core member of the MIATA reporting initiative.

Forward-looking Statements:

This document contains certain forward-looking statements, other than the statements of research facts contained in this press release are forward looking statements. Terms such as “believe”, “estimate”, “anticipate”, “plan”, “predict”, “may”, “hope”, “can”, “will”, “should”, “expect”, “intend”, “is designed to”, “with the intent”, “potential”, the negative of these words or such other variations thereon or comparable terminology, may indicate forward-looking statements, but their absence does not mean that a statement is not forward-looking. These forward-looking statements speak only as of the date of this press release. The events and circumstances reflected in MedGenome’s forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, MedGenome does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Hiranjith GH
MedGenome
7022020883
email us here

Medicare should help with hearing aids

Millions of Americans are cut out of one critical health need for the worst reason of all – money. Hearing loss affects about 30 million Americans to different degrees. It is more common as people get older. And yet there’s a gap in health care options: Medicare does not cover the problem.

And hearing aids are tremendously expensive: $4,700 for a pair including all the associated services. Absent Medicare coverage, people have to pay it out of pocket, and few can write a check, or even look at hefty payment plans, for that kind of money. Private insurance coverage also is uneven and unpredictable.

The National Academy of Sciences, Engineering and Medicine is sounding the alarms about the problem, even though the solutions, or partial solutions, should be obvious and attainable.

One, Medicare should be expanded to cover hearing loss. Two, private insurers should step up with plans of their own. Three, rules governing the sale of hearing aids should be revised. The industry doubtless wants to protect itself, but the simplest hearing aids should be sold over the counter at drugstores.

There’s not that much difference, really, between what would be over-the-counter devices and the reading glasses millions of people buy from drugstores for a fraction of what they’d pay for a prescription from an eye doctor. In fact, many eye doctors tell patients to buy such glasses, if they don’t have other complicating medical problems.

Absent correction, scientists say hearing loss can increase the risk for dementia, for falling, for depression. It’s simply unacceptable for millions of people to go without help.

Do Your Part for the Environment—Go Paperless!

On June 5, more than 100 countries worldwide will be celebrating World Environment Day—a day for encouraging awareness and action for the environment. How can you do your part to help the environment?  One great way is to sign up to get your “Medicare You” handbook electronically.

If you have an eReader (like an iPad, Surface, or Kindle Fire) you can download a free digital version of the “Medicare You” handbook to your eReader and take it with you anywhere you go.

Don’t have an eReader? You can still sign up to get a paperless version in a few simple steps. We’ll send you an email in September when the new eHandbook is available. The email will explain that instead of getting a paper copy in your mailbox each October, you’ll get an email linking you to the online version of “Medicare You.” This online version of the handbook contains all the same information as the printed version.

Even better, the handbook information on Medicare.gov is updated regularly, so you can be confident that you have the most up-to-date Medicare information!

Make a difference this World Environment Day – Go paperless, and sign up to get your “Medicare You” information electronically.

Schemes By Md., Pa. Providers Defrauded Medicaid Of Millions Of Dollars: Courts


The Washington Post:
Md. Couple Sentenced To Prison In $80 Million Medicaid Fraud In Nation’s Capital


A federal judge on Wednesday sentenced a Bowie, Md., wife and husband to 10 and seven years in prison, respectively, for orchestrating a multiyear campaign to defraud D.C. Medicaid of more than $80 million between 2009 and 2014, the largest local health-care fraud scheme ever prosecuted in the city. Florence Bikundi, 53, and Michael D. Bikundi Sr., 63, were ordered to forfeit more than $11 million in cash, their $1 million home and five luxury vehicles by Chief Judge Beryl A. Howell of the U.S. District Court for the District of Columbia, who also imposed a money judgment of $40 million and ordered the couple to pay $80.6 million in restitution. (Hsu, 6/2)

Viewpoints: The Health Law And Its Legal Challenges; Insurer Losses And Risk Pools; Congress And The Zika Debate


Vox:
Unpaid, Stressed, And Confused: Patients Are The Health Care System’s Free Labor


I have spent the past year of my life managing a chronic foot injury. My left foot started hurting after a run last May, and, well, it never really stopped. At best, the injury lies dormant for a few weeks, barely bothering me. At worst, it can cause intense pain to walk my dog down the block. So I’ve spent the past year in doctors’ offices, in MRI scanners, and in late-night Google search sessions trying to understand what went wrong and how to fix it. (Sarah Kliff, 6/1)

Opinion: Expanding Medicare would solve some problems, create new ones

Medicare for more, as I’ve been calling it, would require significant adjustments to the Obamacare new markets for regulated insurance, which are currently set up for everyone under 65. It would require a new system for calculating and awarding subsidies to low-income purchasers. It would probably require changes to Medicare’s standard package of benefits. And it runs the risk of destabilizing the Obamacare marketplaces, several of which are already somewhat precarious.

Epstein-Barr Virus Linked to Anime Voice Actress’s Death; The CBCD Reviews a Report

Voice actress Miyu Matsuki was diagnosed with a chronic Epstein-Barr virus infection, which doctors believe led to her death. (1)

ROCHESTER, NEW YORK, USA, May 30, 2016 /EINPresswire.com/ —

“Infected with the EBV virus? We recommend taking Gene-Eden-VIR or Novirin.” – Greg Bennett, CBCD

The Epstein-Barr Virus (EBV) has been linked to the death of a famous anime voice actress. Myu Matsuki was diagnosed with a chronic infection with the Epstein-Barr Virus, “which eventually led to a terminal case of malignant lymphoma.” (1) Ms. Matsuki, who was famous for roles in ‘Nyaruko: Crawling with Love!’, ‘Hayate the Combat Butler’, and ‘SHIMONETA: A Boring World Where the Concept of Dirty Jokes Doesn’t Exist,’ “announced in July that she would be taking a break from her work to focus on treating her pneumonia, she did not know the cause of her illness.” (1) She passed away on October 27th, 2015.

The Epstein-Barr Virus (EBV) has been linked to a growing number of cancers, including malignant lymphomas, such as Burkitt’s lymphoma-leukemia, nasopharyngeal carcinoma, and adult T-cell leukemia-lymphoma (among others). Individuals become infected with EBV “from mother-to-child transmission, perinatal contact (with genital tract secretions, amniotic fluids, blood, and breast milk), saliva, sexual intercourse, and blood transfusion.” (2)

Click to learn more about EBV symptoms.

The Center for the Biology of Chronic Disease (CBCD) recommends that individuals concerned about an EBV infection take Gene-Eden-VIR or Novirin. The formula of these natural, antiviral products was shown to reduce symptoms of those infected with the Epstein-Barr Virus in two separate, post-marketing clinical studies. These studies followed FDA guidelines.

The formula of Gene-Eden-VIR and Novirin was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the formula of Gene-Eden-VIR and Novirin is effective against the herpes family of viruses. The Epstein Barr Virus (EBV) is a member of the herpes family. The clinical studies were published in the peer reviewed, medical journal Pharmacology Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the EBV … reported a safe decrease in their symptoms following treatment with (the formula of Novirin).” (3) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (3)

Both products can be ordered through their websites here:

http://www.gene-eden-vir.com

and

http://www.novirin.com

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses.

To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.

The CDC notes that “Epstein-Barr Virus (EBV), also known as human herpesvirus 4, is a member of the herpes virus family. It is one of the most common human viruses. EBV is found all over the world. Most people get infected with EBV at some point in their lives.” (4) The Center for the Biology of Chronic Disease (CBCD) recommends that in light of the medical evidence, infected individuals take Gene-Eden-VIR or Novirin. The formula of these natural, antiviral supplements was designed to help the immune system target the latent EBV. Additionally, it was shown to reduce symptoms associated with EBV infection in two separate post-marketing clinical studies that followed FDA guidelines. (4)

What treatments are available for EBV infections?

“A few antiviral drugs are available that were shown to inhibit EBV replication in cell culture. These drugs include the acyclic nucleoside analogues aciclovir, ganciclovir, penciclovir, and their respective prodrugs valaciclovir, valganciclovir and famciclovir, the acyclic nucleotide analogues cidofovir and adefovir, and the pyrophosphate analogue foscarnet. However, clinical studies have shown that these drugs are mostly ineffective in humans.” (3) There are also natural antiviral products that studies show to be safe and effective in reducing EBV symptoms. Two of these products are Novirin and Gene-Eden-VIR.

Find us on Facebook here: https://www.facebook.com/GeneEdenVIR
Follow us on Twitter here: @HananPolansky

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Anime News Network
http://www.animenewsnetwork.com/news/2015-12-15/voice-actress-miyu-matsuki-passed-away-due-to-epstein-barr-virus-lymphoma/.96542

(2) Early-life exposures to infectious agents and later cancer development (- Vedham)
http://onlinelibrary.wiley.com/doi/10.1002/cam4.538/full

(3) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

(4) CDC.com – About Epstein-Barr Virus (EBV). Last updated January 6, 2014. http://www.cdc.gov/epstein-barr/about-ebv.html

Greg Bennett
CBCD
585-250-9999
email us here

CloudMedx adds analytics to identify patients eligible for chronic care management in Medicare

CloudMedx announced new capabilities to its healthcare data analytics platform that enables clinicians and hospital staff to identify, enroll, and track care and treatment for patients in need of chronic care management.

The CloudMedx Analytics Platform combines machine learning and big data analytics to generate real-time health insights in care and treatment to improve patient outcomes. Using predictive risk analyses, CloudMedx helps physicians identify people who are at risk for debilitating illnesses in time for intervention and one-on-one support that can help them reverse their risk or minimize their potential for serious complications, according to a news release. 

[Also: AI, cognitive computing, machine learning are coming: Best time to invest?]

CloudMedx said its analytics platform integrates with labs, pharmacies and hospitals to capture relevant clinical and financial information at the point of care, which is then shared with all necessary healthcare participants across the continuum. 

New features within the CloudMedx Analytics Platform that support CCM include patient engagement, curated care plans, integration of information workflows such as adding multiple EHRs into the care coordination workflow, and staff coordination.

With the new CCM capabilities, healthcare professionals can identify patients who qualify for CCM, engage them in care plans and generate daily and monthly reports on specific CCM activities, such as calls made, time sent and associated eligible payments.

The Centers for Medicare and Medicaid Services pays care providers for delivering CCM services because they save money that would otherwise be spent on costly future events such as complications, hospital readmissions and emergency room visits. CMS estimates that two-thirds of Medicare beneficiaries have two or more chronic conditions. A year and a half into the CCM program, however, CMS data shows this group is underserved. 

[Also: Chronic care management: Is $50 billion market more hype than reality?]

CloudMedx automated the workflow of identifying, stratifying, enrolling, and communicating with patients directly through its portal. And the vendors APIs can allow its analytics platform to be integrated directly into existing workflows and EHRs. 

Twitter: @HealthITNews


Like Healthcare IT News on Facebook and LinkedIn

Listen To Paul Ryan Say That He Cares More About Gutting Medicare Then He Does About Racism

Justice

Jun 3, 2016 2:00 pm

CREDIT: AP Photo/J. Scott Applewhite

U.S. House Speaker Paul Ryan (R-WI) believes that Republican presidential candidate Donald Trump’s recent, racist attack on a federal judge — Trump claimed that Judge Gonzalo Curiel must remove himself from a case involving one of Trump’s companies because Curiel is “of Mexican heritage” — is wrong. But Ryan is voting for Trump anyway.

In an interview with Up Front with Vicki McKenna, a Milwaukee radio show, Ryan said that “the comment about the judge the other day just was out of left field” and that he “completely disagree[s] with the thinking behind that.” But the fact that Trump simultaneously launched a racist attack while calling into question whether he will respect the rule of law if elected president is no reason to vote for a Democrat, Ryan insists.

“If you want to get rid of Obamacare,” Ryan explained, “you need to pass a new law” that the president must sign. “We need a partner in the White House,” the Speaker continued, “to help us advance these bills that we’ve been passing — these conservative reforms that we want to get in law.”

And, in case there is any doubt, that partner is Donald Trump. “It is clear to me,” Ryan said of Trump, “that we have somebody who is a willing partner” in advancing the GOP’s legislative agenda. By contrast, “I know for darn sure Hillary Clinton is going to go in the opposite direction.”

You can listen to Ryan’s explanation why electing a candidate who will repeal Obamacare is more important than preventing a racist with authoritarian tendencies from gaining control of the world’s largest nuclear arsenal here:

It’s worth noting, moreover, that the “conservative reforms” Ryan refers to are far more ambitious than simply rolling back President Obama’s legislative achievements. Ryan’s other plans include voucherizing Medicare in a way that significantly reduces health benefits to seniors, slashing health care for poor people and food stamps, and giving large tax cuts to rich people.

Gov’t Panel Urges Medicare To Find Ways To Make Hearing Loss Treatment More Affordable


The Associated Press:
Medicare Doesn’t Cover Everything


Younger people may not realize it, but seniors know well that Medicare doesn’t cover all health-related needs and expenses. Many Medicare beneficiaries have some kind of supplemental insurance that partly covers the gaps. But those policies mainly provide financial protection for the patient’s share of costs for regular doctor visits and hospital care covered by Medicare. Until 2006, Medicare didn’t cover prescription drugs. (6/2)